Benzinga | Aug 31, 2021 09:52AM EDT

Rigel Pharmaceuticals Granted U.S. Patent Titled 'ACVR2A-specific antibody and method of treatment of muscle atrophy'

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=5413&f=G&l=50&d=PTXT&p=109&S1=20210831&OS=20210831&RS=20210831